83% of peptide-aware Americans want the FDA to make peptides more accessible 83% of peptide-aware Americans want the FDA to make peptides more accessible Days before an FDA advisory committee meets to consider whether seven widely used peptides BPC-157, TB-500, KPV, MOTS-c, Emideltide (DSIP), Semax, and Epitalon should become eligible for compounding, a new survey suggests thats what Americans want
Focus on gentle cleansing, hydration, and sun protection
Unlike ordinary creams that work only on the surface of the skin, glutathione operates deep within the cells
Novo Nordisk plans to initiate phase 3 in 2026
GI-sensitive individuals benefit from extended 16-20 week titrations and may find optimal results at maintenance doses of 1.8-2.0mg weekly rather than pushing to 2.4mg
Because actin dynamics are central to how cells move toward a site of injury, researchers characterise TB-500s activity as broad and systemic rather than confined to one tissue